![]() |
By MedicalWhistleblower (about the author) Page 1 of 1 page(s)
For OpEdNews: MedicalWhistleblower - Writer Medical Whistleblower will be
interviewing Former Eli Lilly executive, Dr. John Virapen Ph.D. on Monday July
27, 2009 at 9 AM Central Time on BlogTalk radio. What he can reveal to us is especially
important in the wake of the recent $1.4 billion settlement from drug maker,
Eli Lilly.John Virapen used to be the executive director of the Swedish
branch of Eli Lilly & Company, one of the biggest internationally active
pharmaceutical companies. Dr. John Virapen has been working for more than 35
years for the pharmaceutical industry, as manager for several companies such as
Eli-Lilly and Novo Nordisk. He lives now in Germany and has written a book,
Side Effects: Death, about his experiences which is available in English, Swedish and German.It is available as a e-book at this link While working for Eli
Lilly, John Virapen engaged in the development of aggressive marketing
strategies, which included to massive corruption in more than one occasion. He
participated in the resolute distribution of drugs, which cause massive and dangerous
side effects like the death of the patient. Pharmaceutical companies
invest the considerable amount of 35,000 Euro per year and physician to get the
physicians to prescribe their products. John Virapen says that more than
75 percent of leading scientists in the field of medicine are paid for by the
pharmaceutical industry. In some cases corruption prevailed in the
approval and marketing of drugs. John Virapen writes that illnesses are
made up by the pharmaceutical industry and specifically marketed to enhance
sales and market shares for the companies in question. Pharmaceutical
companies increasingly target children.
http://www.side-effects-death.com/tag/john-virapen
The drug giant, Eli Lilly, recently pleaded guilty to promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA). Eli Lilly was found guilty of pushing Zyprexa for extra label uses, withholding research to the public and false advertising. The criminal fine of $515 million is the largest ever in a health care case, and the largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution of any kind. Eli Lilly will also pay up to $800 million in a civil settlement with the federal government and the states.
There have been years of withheld information regarding the adverse side effects of pharmaceuticals promoted by Eli Lilly, including the possible role of Prozac in inducing suicide and homicide. The signs of drug induced violence and suicidality were there since Prozac was first tested in pre-marketing trials. There were suppressed clinical reports of Prozac's adverse side effects including psychotic episodes, completed suicides and attempted suicides. Long term effects of the use of SSRI's like Zyprexa have not been fully independently studied but these drugs are routinely prescribed for long term use. Preliminary studies of some of Eli Lilly's drugs pointed to serious potential adverse side effects of chronic use including: debilitating movement disorders, seizures, cardiac problems, diabetes and Parkinson's disease.
Hear Dr. John Rengen Virapen live on www.BlogTalkRadio.com/medicalwhistleblower at 9 AM Central Time 7/27/09 interviewed by Dr. Janet Parker DVM, Executive Director of Medical Whistleblower. Call in (347) 857-4599.
See him on YouTube: http://www.youtube.com/watch?v=s-8ItXRMPfA
Read about his story on the web at: http://1phil4everyill.wordpress.com/2009/07/09/14-dr-john-rengen-virapen-blows-the-whistle-on-his-former-big-pharma-employer/
Take action -- click here to contact your local newspaper or congress people:
Pharmaceutical Marketing Hides Adverse Effects of Drugs
Click here to see the most recent messages sent to congressional reps and local newspapers
The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.
Contact Author |
Contact Editor |
View Authors' Articles |
| No comments |
Want to post your own comment on this Article?
|
||||
Tell a Friend:
|
Copyright © 2002-2009, OpEdNews |